Researchers track rare nerve disease to unlock future treatments
NCT ID NCT06151600
First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times
Summary
This study follows 20 people with a rare nerve disease called CMT4J for up to 2 years. Researchers will track symptoms and health changes to better understand how the disease progresses. The goal is to find better ways to measure the disease, which could help design future treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHARCOT-MARIE-TOOTH DISEASE TYPE 4J are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stanford University
San Francisco, California, 94305, United States
-
University of Iowa
Iowa City, Iowa, 52242, United States
-
University of Texas Southwestern
Dallas, Texas, 75390, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can MRI scans reveal how ANO5 muscle disease progresses?
- Could sharing lived experiences ease the burden of dementia care?
- Could a simple blood test track nerve damage? a study investigates NT-3 levels in neuropathy.
- Tissue donations could unlock secrets of muscle diseases
- Smartphone sensors and apps could revolutionize monitoring of rare muscle diseases